Adjuvant radiotherapy in carcinomas of the uterine cervix: The prognostic value of hemoglobin levels

International Journal of Gynecological Cancer

Volumn 15, Issue 2, 2005, Pages 285-291

  Munstedt K ^a,b   Johnson, P ^a   Bohlmann, M K ^a   Zygmunt, M ^a   Von Georgi, R ^a   Vahrson, H ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b NONE   (Germany)

Author keywords

Cervical cancer; Hemoglobin; Prognosis; Radiotherapy

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER;

ADULT; AGED; ANEMIA; CARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HEMOGLOBINS; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 15444371162     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.15217.x     Document Type: Article

References (27)

1. Einhorn N, Trope CG, Ridderheim M, Boman K, Sorbe B, Cavallin-Stahl E. A systematic overview of radiation therapy effects in cervical cancer (cervix uteri). Acta Oncol 2003;42:546-56.
2. Lukka H, Hirte H, Fyles A et al. Cancer Care Ontario Practice Guidelines Initiative Gynecology Disease Site Group. Clin Oncol (R Coll Radiol) 2002;14:203-12.
3. Landoni F, Maneo A, Colombo A et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997;350:535-40.
4. Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ. A randomised trial of pelvic radiation therapy versus no further therapy in selected patients with stage Ib carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group study Gynecol Oncol 1999;73:177-83.
5. Lai CH, Hong JH, Hsueh S et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer 1999;85:1537-46.
6. Okada M, Kigawa J, Minagawa Y et al. Indication and efficacy of radiation therapy following radical surgery in patients with stage IB to IIB cervical cancer. Gynecol Oncol 1998;70:61-4.
7. Hong JH, Tsai CS, Lai CH et al. Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis. Int J Radiat Oncol Biol Phys 2002;53:1284-90.
8. Tsai CS, Lai CH, Wang CC et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol Oncol 1999;75:328-33.
9. Hofmann D. Klinik der gynäkologischen Strahlentherapie. Berlin: Urban & Schwarzenberg, 1963:280-7.
10. Grogan M, Thomas GM, Melamed I et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 1999;86:1528-36.
11. Obermair A, Cheuk R, Horwood K et al. Impact of hemoglobin levels before and during concurrent chemoradiotherapy on the response of treatment in patients with cervical carcinoma: preliminary results. Cancer 2001;92:903-8.
12. Girinski T, Pejovic-Lenfant MH, Bourhis J et al. Prognostic value of hemoglobin concentrations and blood transfusions in advanced carcinoma of the cervix treated by radiation therapy: results of a retrospective study of 386 patients. Int J Radiat Oncol Biol Phys 1989;16:37-42.
13. Rofstad EK, Sundfor K, Lyng H, Tropé CG. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. Br J Cancer 2000;83:354-9.
14. Nowrousian MR. Classification and characterization of anemia in cancer. In: Nowrousian MR, ed. Recombinant human erythropoietin (rhEPO) in clinical oncology. Wien, New York: Springer, 2002:23-38.
15. Morrow CP, Shingleton HM, Averette HE et al. Is pelvic radiation beneficial in the postoperative management of stage IB squamous cell carcinoma of the cervix pelvic node metastasis treated by radical hysterectomy and pelvic lymphadenectomy? A report from the Presidential panel at the 1979 Annual Meeting of the Society of Gynecological Oncologists. Gynecol Oncol 1980;10:105-10.
16. Fuller AF, Elliott N, Kosloff C et al. Lymph node metastasis from carcinoma of the cervix, stages IB and IIA: implications for prognosis and treatment. Gynecol Oncol 1982;13:165-74.
17. Kinney WK, Alvarez RD, Reid GC et al. Value of adjuvant whole-pelvis irradiation after Wertheim hysterectomy for early-stage squamous carcinoma of the cervix with nodal metastasis: a matched-control study. Gynecol Oncol 1989;34:258-65.
18. Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000;342:1878-86.
19. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
20. Chen SW, Liang JA, Yang SN, Lin FJ. Postoperative radiotherapy for patients with invasive cervical cancer following treatment with simple hysterectomy. Jpn J Clin Oncol 2003;33:477-81.
21. Kimura E, Ochiai K, Okamura K et al. Investigation of the long-term outcome and postoperative cell mediated immunity in patients who received autologous blood transfusion and homologous blood transfusion in surgery for gynecologic cancer (a multi-center study) [abstract]. Proc Am Soc Clin Oncol 2002;21:225. Abstract 898.
22. Wun T, Law L, Harvey D, Sieracki B, Scudder SA, Ryu JK. Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin. Cancer 2003;98:1514-20.
23. Henke M, Laszig R, Rübe C et al. Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomized, double-blind, placebo-controlled trial. Lancet 2002;362:1255-60.
24. Fyles AW, Milosevic M, Pintilie M, Syed A, Hill RP. Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 2000;57:13-9.
25. Blohmer JU, Wurschmidt F, Petry U et al. Sixth interim analysis of a prospective, randomized, open and controlled AGO- and NOGGO-intergroup study: sequential adjuvant chemo-radiotherapy with vs without epoetin alfa for pts with high-risk cervical cancer [abstract]. Proc Am Soc Clin Oncol 2003;22:447. Abstract 1798.
26. Curtin JP, Hoskins WJ, Venkatraman ES et al. Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial. Gynecol Oncol 1996;61:3-10.
27. Tattersall MH, Ramirez C, Coppleson M. A randomized trial of adjuvant chemotherapy after radical hysterectomy in stage Ib-IIa cervical cancer patients with pelvic lymph node metastases. Gynecol Oncol 1992;42:176-81.